CELLINK

CELLINK

Forskning inom bioteknik

Create the future of health

Om oss

CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company. By releasing the first universal bioink in 2016, CELLINK democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into a thriving $1 billion industry. The company’s best-in-class bioinks, bioprinters, software and services are trusted by the foremost academics in a range of applications, from 3D cell culturing to tissue engineering to drug development, and have been cited in over 700 publications. Furthermore, more than 1,000 laboratories, including ones at the top 20 pharmaceutical companies, are using these award-winning innovations. As part of BICO’s bioconvergence revolution, CELLINK is dedicated to making the on-demand bioprinting of human organs and tissues a future reality and creating the future of health.

Webbplats
https://www.cellink.com/
Bransch
Forskning inom bioteknik
Företagsstorlek
201–500 anställda
Huvudkontor
Gothenburg
Typ
Publikt aktiebolag
Specialistområden
biotechnology, Bioprinting, medicine, cell biology, research, biotech, regenerative medicine, stem cell research, bioink och biology

Adresser

Anställda på CELLINK

Uppdateringar

Anslutna sidor

Liknande sidor

Finansiering

CELLINK 2 rundor totalt

Senaste finansieringsrunda

Anslag

211 136,00 US$

Investerare

Vinnova
Se mer info på crunchbase